Approvals/TGA/HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial

Approved

STANDARD

HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8c160915b72eefab
Product Name: HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
Artg Id: 293758
Artg Name: HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2018-02-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/189554dd930fa9ab5d1b301d9927ad05.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c81694eba78fef46fd3e99fda5496edb.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8c160915b72eefab

Type

Standard